Cite

HARVARD Citation

    Wang, Y. et al. (2022). Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation. 106 (2), pp. 412-419. [Online]. 
  
Back to record